罕见病研究:面部肉芽肿合并多发性大动脉炎1例

廖威, 龙娟, 汤建萍, 呙丹妮, 树叶, 韦祝

中国当代儿科杂志 ›› 2025, Vol. 27 ›› Issue (10) : 1266-1270.

PDF(885 KB)
HTML
PDF(885 KB)
HTML
中国当代儿科杂志 ›› 2025, Vol. 27 ›› Issue (10) : 1266-1270. DOI: 10.7499/j.issn.1008-8830.2504185
罕见病研究

罕见病研究:面部肉芽肿合并多发性大动脉炎1例

作者信息 +

Granuloma faciale and Takayasu arteritis in a child: a case report

Author information +
文章历史 +

摘要

男性患儿,11岁,因双侧下颌、颏部红色斑块2年,咳嗽气促2个月余就诊。胸部计算机体层成像血管造影提示右肺动脉明显狭窄,主动脉粗细不均及管壁增厚。皮肤活检结合免疫组织化学、特殊染色结果符合皮肤慢性化脓性炎症。全外显子组测序阴性。最终患儿诊断为面部肉芽肿、多发性大动脉炎。在托珠单抗、泼尼松、氨甲蝶呤系统治疗及0.1%他克莫司软膏外用的联合治疗下,取得了良好的临床效果。该文总结了1例面部肉芽肿合并多发性大动脉炎患儿的临床资料,对其病因、诊断、最新治疗方法进行归纳总结,为临床医生诊断该类罕见疾病提供思路。

Abstract

An 11-year-old boy presented with erythematous plaques over the bilateral mandibular and mental regions for 2 years, accompanied by cough and dyspnea for more than 2 months. Chest computed tomography angiography revealed marked stenosis of the right pulmonary artery, irregular aortic caliber, and aortic wall thickening. Histopathological examination of the skin lesion, including immunohistochemistry and special stains, confirmed a chronic suppurative inflammation. Whole-exome sequencing was negative. A final diagnosis of granuloma faciale and Takayasu arteritis was established. Combination therapy with systemic tocilizumab, prednisone, and methotrexate, along with topical 0.1% tacrolimus ointment, resulted in a favorable clinical response. This report summarizes the clinical features of a pediatric case of granuloma faciale and Takayasu arteritis and reviews the etiology, diagnostic approach, and current treatment strategies for the disorders, aiming to enhance clinicians' understanding of these conditions.

关键词

面部肉芽肿 / 多发性大动脉炎 / 儿童

Key words

Granuloma faciale / Takayasu arteritis / Child

引用本文

导出引用
廖威, 龙娟, 汤建萍, . 罕见病研究:面部肉芽肿合并多发性大动脉炎1例[J]. 中国当代儿科杂志. 2025, 27(10): 1266-1270 https://doi.org/10.7499/j.issn.1008-8830.2504185
Wei LIAO, Juan LONG, Jian-Ping TANG, et al. Granuloma faciale and Takayasu arteritis in a child: a case report[J]. Chinese Journal of Contemporary Pediatrics. 2025, 27(10): 1266-1270 https://doi.org/10.7499/j.issn.1008-8830.2504185

参考文献

[1]
Al Dhafiri M, Kaliyadan F. Granuloma Faciale[M]//StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2025.
[2]
Sia JK, Rengarajan J. Immunology of Mycobacterium tuberculosis infections[J]. Microbiol Spectr, 2019, 7(4): 10.1128/microbiolspec.gpp3-0022-2018. PMID: 31298204 PMCID:PMC6636855. DOI: 10.1128/microbiolspec.GPP3-0022-2018 .
[3]
Fang YH, Wei KC, Yu MS. Improvement of erythema elevatum diutinum refractory to dapsone following treatment for underlying multiple myeloma[J]. Eur J Dermatol, 2021, 31(5): 655-657. DOI: 10.1684/ejd.2021.4131 .
[4]
Marcoval J, Moreno A, Peyr J. Granuloma faciale: a clinicopathological study of 11 cases[J]. J Am Acad Dermatol, 2004, 51(2): 269-273. DOI: 10.1016/j.jaad.2003.11.071 .
[5]
Stone JH, Khosroshahi A, Zhang W, et al. Inebilizumab for treatment of IgG4-related disease[J]. N Engl J Med, 2025, 392(12): 1168-1177. DOI: 10.1056/NEJMoa2409712 .
[6]
Cesinaro AM, Lonardi S, Facchetti F. Granuloma faciale: a cutaneous lesion sharing features with IgG4-associated sclerosing diseases[J]. Am J Surg Pathol, 2013, 37(1): 66-73. DOI: 10.1097/PAS.0b013e318271efd0 .
[7]
Pinkus H. Granuloma faciale[J]. Dermatologic, 1952, 105(2): 85-99.
[8]
Oliveira CC, Ianhez PE, Marques SA, et al. Granuloma faciale: clinical, morphological and immunohistochemical aspects in a series of 10 patients[J]. An Bras Dermatol, 2016, 91(6): 803-807. PMCID: PMC5193193. DOI: 10.1590/abd1806-4841.20164628 .
[9]
Ortonne N, Wechsler J, Bagot M, et al. Granuloma faciale: a clinicopathologic study of 66 patients[J]. J Am Acad Dermatol, 2005, 53(6): 1002-1009. DOI: 10.1016/j.jaad.2005.08.021 .
[10]
Chen A, Harview CL, Rand SE, et al. Refractory granuloma faciale successfully treated with adjunct topical JAK inhibitor[J]. JAAD Case Rep, 2023, 33: 91-94. PMCID: PMC9989295. DOI: 10.1016/j.jdcr.2023.01.016 .
[11]
Nakahara T, Moroi Y, Tashiro A, et al. The interaction of inflammatory cells in granuloma faciale[J]. Dermatol Reports, 2010, 2(2): e17. PMCID: PMC4211470. DOI: 10.4081/dr.2010.e17 .
[12]
Lindhaus C, Elsner P. Granuloma faciale treatment: a systematic review[J]. Acta Derm Venereol, 2018, 98(1): 14-18. DOI: 10.2340/00015555-2784 .
[13]
Giannitti C, Nami N, Rubegni P, et al. Granuloma faciale, rheumatoid arthritis and Sjögren syndrome: is there a link?[J]. J Cutan Pathol, 2013, 40(8): 770-771. DOI: 10.1111/cup.12115 .
[14]
Sambhariya WS, Campbell A. Rapidly growing eyelid lesion in a 73-year-old man[J]. JAMA Ophthalmol, 2024, 142(8): 777-778. DOI: 10.1001/jamaophthalmol.2024.1807 .
[15]
Morgado-Carrasco D, Giavedoni P, Mascaró JM, et al. Assessment of treatment of refractory granuloma faciale with intralesional rituximab[J]. JAMA Dermatol, 2018, 154(11): 1312-1315. PMCID: PMC6248127. DOI: 10.1001/jamadermatol.2018.2681 .
[16]
李天英, 郑松. 面部肉芽肿一例[J]. 中华病理学杂志, 2017, 46(10): 729-730. DOI: 10.3760/cma.j.issn.0529-5807.2017.10.016 .
[17]
赵梦洁, 蒋思, 宋继权. 0.1%他克莫司软膏治疗面部肉芽肿1例[J]. 中华皮肤科杂志, 2024, 57(2): 168-169. DOI: 10.35541/cjd.20210512 .
[18]
Mastorino L, Avallone G, Dapavo P, et al. Tocilizumab and its usage for skin diseases[J]. Ital J Dermatol Venerol, 2022, 157(1): 13-22. DOI: 10.23736/S2784-8671.20.06772-3 .
[19]
刘娟, 曹雪涛. 2024年国内外免疫学研究重要进展[J]. 中国免疫学杂志, 2025, 41(1): 1-10. DOI: 10.3969/j.issn.1000-484X.2025.01.001 .
[20]
Nakaoka Y, Yanagawa M, Hata A, et al. Vascular imaging of patients with refractory Takayasu arteritis treated with tocilizumab: post hoc analysis of a randomized controlled trial[J]. Rheumatology (Oxford), 2022, 61(6): 2360-2368. PMCID: PMC9157117. DOI: 10.1093/rheumatology/keab684 .
[21]
Li H, Shuai Z. Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review[J]. Heart Vessels, 2022, 37(5): 884-894. PMCID: PMC8986741. DOI: 10.1007/s00380-021-01981-1 .

脚注

所有作者声明无利益冲突。

基金

湖南省自然科学基金(2022JJ40199)

编委: 王颖

版权

版权所有 © 2023中国当代儿科杂志
PDF(885 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/